🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: to assess the antitumor activity and safety profile of c...
Status
Completed
Location
Fujian Provincial Tumor Hospital
Start Date
2009-02
Trial ID
NCT01012258
Treatments Being Tested
This phase II trial studies how well radiation therapy and cisplatin with o...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2020-01-14
Trial ID
NCT04106362
Treatments Being Tested
This phase III trial compares cetuxumab to chemotherapy, carboplatin and pa...
Status
Recruiting
Location
Tower Cancer Research Foundation
Start Date
2026-07-31
Trial ID
NCT07441681
RATIONALE: Monoclonal antibodies such as cetuximab can locate tumor cells a...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2004-04
Trial ID
NCT00084318
Treatments Being Tested
A phase III trial of induction chemotherapy followed by definitive radiothe...
Status
Unknown
Location
Ospedale S. Giacomo
Start Date
2009-09
Trial ID
NCT00999700
Treatments Being Tested
Verify the effect and the incidence of oral mucositis of concurrent chemora...
Status
Unknown
Location
Multiple Locations
Start Date
2016-04
Trial ID
NCT02753140
The purpose is to assess the overall survival of patients receiving either ...
Status
Terminated
Location
Kent Oncology Centre
Start Date
2009-03
Trial ID
NCT01050426
Treatments Being Tested
The purpose of this study is to evaluate the results of treating patients w...
Status
Active Not Recruiting
Location
Washington University School of Medicine
Start Date
2018-04-27
Trial ID
NCT03389477
To compare the Disease free survival (DFS) rate of a preoperative cetuximab...
Status
Unknown
Location
Rabin Medical Center
Start Date
2013-01
Trial ID
NCT01760811
Treatments Being Tested
This is a Phase I dose-escalation study of sEphB4-HSA in combination with c...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-01-06
Trial ID
NCT04091867
Treatments Being Tested